Literature DB >> 29152032

LATENT CLASS MODELING USING MATRIX COVARIATES WITH APPLICATION TO IDENTIFYING EARLY PLACEBO RESPONDERS BASED ON EEG SIGNALS.

Bei Jiang1, Eva Petkova2,3, Thaddeus Tarpey4, R Todd Ogden5.   

Abstract

Latent class models are widely used to identify unobserved subgroups (i.e., latent classes) based upon one or more manifest variables. The probability of belonging to each subgroup is typically modeled as a function of a set of measured covariates. In this paper, we extend existing latent class models to incorporate matrix covariates. This research is motivated by a randomized placebo-controlled depression clinical trial. One study goal is to identify a subgroup of subjects who experience symptoms improvement early on during antidepressant treatment, which is considered to be an indication of a placebo rather than a true pharmacological response. We want to relate the likelihood of belonging to this subgroup of early responders to baseline electroencephalography (EEG) measurement that takes the form of a matrix. The proposed method is built upon a low rank Candecomp/Parafac (CP) decomposition of the target coefficient matrix through low-dimensional latent variables, which effectively reduces the model dimensionality. We adopt a Bayesian hierarchical modeling approach to estimate the latent variables, which allows a flexible way to incorporate prior knowledge about covariate effect heterogeneity and offers a data-driven method of regularization. Simulation studies suggest that the proposed method is robust against potentially misspecified rank in the CP decomposition. With the motivating example we show how the proposed method can be applied to extract valuable information from baseline EEG measurements that explains the likelihood of belonging to the early responder subgroup, helping to identify placebo responders and suggesting new targets for the study of placebo response.

Entities:  

Keywords:  Bayesian hierarchical modeling; Candecomp/Parafac (CP) matrix decomposition; data-driven regularization; major depression; placebo effect

Year:  2017        PMID: 29152032      PMCID: PMC5687521          DOI: 10.1214/17-AOAS1044

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  28 in total

1.  Finite mixture modeling with mixture outcomes using the EM algorithm.

Authors:  B Muthén; K Shedden
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

Authors:  Gerard E Bruder; James P Sedoruk; Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin; Craig E Tenke
Journal:  Biol Psychiatry       Date:  2007-12-03       Impact factor: 13.382

3.  MPCA: Multilinear Principal Component Analysis of Tensor Objects.

Authors:  Haiping Lu; Konstantinos N Kostas Plataniotis; Anastasios N Venetsanopoulos
Journal:  IEEE Trans Neural Netw       Date:  2008-01

4.  Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.

Authors:  J W Stewart; F M Quitkin; P J McGrath; J Amsterdam; M Fava; J Fawcett; F Reimherr; J Rosenbaum; C Beasley; P Roback
Journal:  Arch Gen Psychiatry       Date:  1998-04

5.  Latent Regression Analysis.

Authors:  Thaddeus Tarpey; Eva Petkova
Journal:  Stat Modelling       Date:  2010-07-01       Impact factor: 2.039

Review 6.  The use of current source density as electrophysiological correlates in neuropsychiatric disorders: A review of human studies.

Authors:  Chella Kamarajan; Ashwini K Pandey; David B Chorlian; Bernice Porjesz
Journal:  Int J Psychophysiol       Date:  2014-11-06       Impact factor: 2.997

Review 7.  Predictors of drug response in depression.

Authors:  P R Joyce; E S Paykel
Journal:  Arch Gen Psychiatry       Date:  1989-01

8.  Changes in brain function of depressed subjects during treatment with placebo.

Authors:  Andrew F Leuchter; Ian A Cook; Elise A Witte; Melinda Morgan; Michelle Abrams
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

9.  Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling.

Authors:  Bengt Muthén; Hendricks C Brown
Journal:  Stat Med       Date:  2009-11-30       Impact factor: 2.373

Review 10.  Studying depression using imaging and machine learning methods.

Authors:  Meenal J Patel; Alexander Khalaf; Howard J Aizenstein
Journal:  Neuroimage Clin       Date:  2015-11-10       Impact factor: 4.881

View more
  1 in total

1.  A Bayesian approach to joint modeling of matrix-valued imaging data and treatment outcome with applications to depression studies.

Authors:  Bei Jiang; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  Biometrics       Date:  2019-11-14       Impact factor: 2.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.